Dr. Akinsola is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3807 Clairmont Rd
Chamblee, GA 30341Phone+1 917-370-4485Fax+1 877-914-7472
Education & Training
BronxCare Health SystemResidency, Pediatrics, 2009 - 2012
University of Ilorin Faculty of Health SciencesClass of 1997
Certifications & Licensure
GA State Medical License 2012 - 2026- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- Safety and Immunogenicity of SARS-CoV-2 Spike Receptor-Binding Domain andN-Terminal Domain mRNA Vaccine.Spyros Chalkias, Antionette Pragalos, Adebayo Akinsola, Gary Berman, Madhavi Ampajwala
The Journal of Infectious Diseases. 2025-01-10 - 16 citationsAntibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2–29 YearsAldiouma Diallo, Samba O. Sow, Olubukola T. Idoko, Siddhivinayak Hirve, Helen Findlow
Clinical Infectious Diseases. 2015-11-15 - 12 citationsAntibody Persistence 1–5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12–23 Months of AgeMilagritos D. Tapia, Helen Findlow, Olubukola T. Idoko, Marie-Pierre Preziosi, Prasad S. Kulkarni
Clinical Infectious Diseases. 2015-11-15
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
